Magpie Pharmaceuticals
About:
Magpie Pharmaceuticals is a biotechnology company.
Website: http://magpiepharma.com
Top Investors: Wonderland Capital, BOC & Utrust Private Equity Fund Management, Sangel Capital, Canton Venture Capital, Zhejiang Conba Pharmaceutical
Description:
Magpie Pharmaceuticals specialize in the research and development of first-in-class drugs. The company focuses on the structural modification and transformation of active natural product monomers in traditional Chinese medicines (TCM), as well as small molecular compounds currently in clinical use.
Total Funding Amount:
$28.8M
Headquarters Location:
Guangzhou, Guangdong, China
Founded Date:
2010-01-01
Founders:
Dr. Yuqiang Wang
Number of Employees:
51-100
Last Funding Date:
2020-04-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai